August 1, 2008  

ESP Portfolio Company -- EKR Therapeutics Receives Approval for Ready-to-Use Intravenous Bags of Cardene ® I.V.

  March 10, 2008  

ESP Equity further increases its investment stake in EKR Therapeutics , Inc. in the lastest $145 million financing . General Partners Howard Weisman and S.Douglas Sheldon both serve on the board

  February 4, 2008  

EKR THERAPEUTICS AND PDL BIOPHARMA SIGN ASSET PURCHASE AGREEMENT FOR CARDIOVASCULAR PRODUCTS

  AUGUST 16, 2007  

ESP Equity Partners continues its support for EKR Therapeutics in Series C Financing

  AUGUST 15, 2007  

EKR Therapeutics Raises Over $13 Million in a Series C Financing Round From New and Existing Investors

EKR Therapeutics Achieves Key Growth Milestone with the Acquisition of Rights from Pacira Pharmaceuticals to DepoDurŪ, a Novel Extended -Release Opioid Analgesic for Post Operative Pain

  JUNE 27, 2006  

ESP Pharma Founder Launches EKR Therapeutics with Financing Led by NewSpring Capital and ESP Equity Partners

MAY 3, 2005  

ESP PHARMA co-founders open private equity firm ESP EQUITY PARTNERS, LLC.

Copyright ©2005 ESP Equity Partners LLC

Home

Support

Contacts